Is 3D Printing of Pharmaceuticals a Disruptor or Enabler?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 30506794.
- Also identified by DOI 10.1002/adma.201805680.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Additive manufacturing (AM) is a fast-growing manufacturing approach that comes with the promise of delivering personalized medicine to treat individual patients. However, large-scale commercial applications in the pharmaceutical industry have been limited. Here, some of the challenges are discussed along with some pharmaceutical products where AM has the potential to make a tangible impact and pave the way for more rapid adoption are highlighted.
Medical subject headings
- Pharmaceutical Preparations
- Printing, Three-Dimensional